周小栋, 廖坚, 周晓柱. 慢性肾脏病患者经皮冠脉介入术后血小板反应性及其相关因素分析[J]. 临床肾脏病杂志, 2022, 22(10): 800-806. DOI: 10.3969/j.issn.1671-2390.2022.10.002
    引用本文: 周小栋, 廖坚, 周晓柱. 慢性肾脏病患者经皮冠脉介入术后血小板反应性及其相关因素分析[J]. 临床肾脏病杂志, 2022, 22(10): 800-806. DOI: 10.3969/j.issn.1671-2390.2022.10.002
    Zhou Xiao-dong, Liao Jian, Zhou Xiao-zhu. Platelet reactivity and related factors in patients with chronic kidney disease after percutaneous coronary intervention[J]. Journal of Clinical Nephrology, 2022, 22(10): 800-806. DOI: 10.3969/j.issn.1671-2390.2022.10.002
    Citation: Zhou Xiao-dong, Liao Jian, Zhou Xiao-zhu. Platelet reactivity and related factors in patients with chronic kidney disease after percutaneous coronary intervention[J]. Journal of Clinical Nephrology, 2022, 22(10): 800-806. DOI: 10.3969/j.issn.1671-2390.2022.10.002

    慢性肾脏病患者经皮冠脉介入术后血小板反应性及其相关因素分析

    Platelet reactivity and related factors in patients with chronic kidney disease after percutaneous coronary intervention

    • 摘要: 目的 探讨慢性肾脏病(chronic kidney disease,CKD)合并急性冠脉综合征(acute coronary syndrome,ACS)患者经皮冠脉介入术(percutaneous coronary intervention,PCI)后血小板反应性及其影响因素分析。方法 以湖北江汉油田总医院2019年1月至2021年8月收治的ACS合并CKD患者为观察组(n=40),另选取同期单纯ACS患者为对照组(n=40)。所有患者均给予标准的双联抗血小板治疗,待药物正常反应后采用光学比浊法测定血小板反应性,比较两组患者二磷酸腺苷(adenosine diphosphate,ADP)诱导的血小板聚集率,分析CKD分期与血小板聚集率的相关性并分析导致高血小板反应性(high platelet reactivity,HPR)的相关因素。结果 观察组ADP诱导血小板聚集率明显高于对照组[(38.41±8.79)%比(23.34±9.81)%],差异具有统计学意义(P<0.05);随着CKD分期的升高,ADP诱导的血小板聚集率逐渐升高(F趋势=13.456,P<0.05); CKD分期与血小板聚集率呈正相关关系(ρ=0.640,P<0.05); HPR组患者年龄、2型糖尿病比例、血管病变≥3支比例和CKD比例明显高于非HPR组,血红蛋白水平及25-羟维生素D水平低于非HPR组,差异具有统计学意义(P<0.05);对于非CKD患者,2型糖尿病(OR=8.641)、血管病变≥3支(OR=10.205)是导致ACS患者PCI术后血小板高反应性的独立危险因素(P<0.05);对于CKD患者,2型糖尿病(OR=7.640)、血管病变≥3支(OR=13.098)、低血红蛋白水平(OR=0.968)及低25-羟维生素D水平(OR=0.674)是导致ACS患者PCI术后血小板高反应性的独立危险因素(P<0.05)。结论 相比于非CKD患者,CKD合并ACS患者PCI术后血小板反应性较高,且与CKD分期呈正相关关系;贫血以及低维生素D水平也是CKD患者PCI术后HPR的独立危险因素。

       

      Abstract: Objective To explore the platelet reactivity and its influencing factors in patients with chronic kidney disease(CKD)and acute coronary syndrome(ACS)after percutaneous coronary intervention(PCI). Methods From January 2019 to August 2021,40 ACS patients with CKD receiving PCI were selected as observation group. Another 40 ACS patients receiving PCI during the same period were assigned into control group. All patients received standard dual antiplatelet therapy. During normal dosing,platelet reactivity was measured by LTA method and platelet aggregation rate induced by ADP compared between two groups. Spearman’ s linear equation was utilized for examining the correlation between platelet aggregation rate induced by ADP and severity of CKD. ADP-induced platelet aggregation rate >40% was defined as high platelet reactivity(HPR). Based on the results,it is divided into two groups of HPR and non-HPR. Clinical data of two groups were compared. Multi-factor Logistic regression equation was employed for examining the related factors of HPR. Results Platelet aggregation rate induced by ADP was significantly higher in observation group than that in control group[(38.41±8.79) % vs(23.34±9.81) %]and the difference was statistically significant(P<0.05); with greater severity of CKD,platelet aggregation rate induced by ADP gradually rose(FTrend=13.456,P<0.05); Spearman’ s linear correlation analysis indicated that ADP-induced platelet aggregation rate was positively correlated with severity of CKD(ρ=0.640,P<0.05);age,proportion of type 2 diabetes mellitus (T2DM),proportion of vascular disease ≥3 and ratio of CKD were significantly higher in HPR group than those in non-HPR group;levels of hemoglobin and 25 hydroxyvitamin D were lower in HPR group than those in non-HPR group(P<0.05);Multivariate Logistic regression analysis revealed that T2DM (OR=8.641)and vascular disease ≥3 vessels(OR=10.205)were independent risk factors for HPR in ACS patients after PCI(P<0.05). For CKD patients,T2DM(OR=7.640),vascular lesions ≥3(OR =13.098),low hemoglobin(OR=0.968)and low 25 hydroxyvitamin D(OR=0.674)were the independent risk factors of HPR in ACS patients after PCI(P<0.05). Conclusion As compared with nonCKD counterparts,CKD patients with ACS have higher platelet reactivity after PCI. And it is positively correlated with severity of CKD. Anemia due to CKD and low vitamin D are also independent risk factors for HPR.

       

    /

    返回文章
    返回